IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) will announce its earnings results before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $2.69 per share for the quarter. IDEXX Laboratories has set its FY 2024 guidance at 10.310-10.590 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $2.44 EPS for the quarter, missing analysts’ consensus estimates of $2.88 by ($0.44). The company had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. IDEXX Laboratories had a net margin of 22.34% and a return on equity of 57.03%. IDEXX Laboratories’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $2.67 EPS. On average, analysts expect IDEXX Laboratories to post $10 EPS for the current fiscal year and $12 EPS for the next fiscal year.
IDEXX Laboratories Price Performance
IDXX opened at $457.90 on Thursday. The stock has a fifty day moving average of $486.11 and a 200-day moving average of $490.23. The firm has a market capitalization of $37.82 billion, a P/E ratio of 44.33, a PEG ratio of 4.14 and a beta of 1.33. IDEXX Laboratories has a 12-month low of $372.50 and a 12-month high of $583.39. The company has a quick ratio of 1.03, a current ratio of 1.37 and a debt-to-equity ratio of 0.33.
Wall Street Analysts Forecast Growth
IDEXX Laboratories Company Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Featured Articles
- Five stocks we like better than IDEXX Laboratories
- How to Use the MarketBeat Stock Screener
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Why is the Ex-Dividend Date Significant to Investors?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Invest in the FAANG Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.